Neuome

Bengaluru, India Founded: 2020 • Age: 6 yrs
Therapeutic, prophylactic, and diagnostic technologies are developed for lifesciences.

About Neuome

Neuome is a Healthcare company based in Bengaluru (India) founded in 2020 by Rajani Kanth Vangala. Therapeutic, prophylactic, and diagnostic technologies are developed for lifesciences. Neuome has raised $361.96 thousand across 1 funding round from investors including Dr Lal PathLabs. The company has 28 employees. Its chief executive, as recorded, is Rajani Kanth Vangala. Its Indian entity Neuome Technologies Private Limited reported revenue of β‚Ή14.3 Lakh. Neuome offers products and services including instaPRESERVE, InstaDetect, and Biobank. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.

Company details

Neuome was founded in 2020 and is based in Bengaluru, India. Technologies for therapeutic, prophylactic, and diagnostic applications in the lifesciences sector are developed by the company. Key products include the InstaDetect Pathogen Diagnostic Kit Platform and the InstaPreserve RT system for biospecimen collection, transport, and storage. Research services are provided to tackle challenges in pharmaceutical and biotechnology research and development.

Key Metrics
  • Annual Revenue
    ₹14.3 Lakh

    FY 2025 · -97% YoY

  • Net Loss
    -₹1.07 Cr

    FY 2025 · -747% margin

  • EBITDA
    -₹68.8 Lakh

    FY 2025 · -480% margin

  • Total Equity Funding
    $361.96K (USD)

    in 1 rounds

  • Latest Funding Round
    $361.96K (USD), Seed

    Jul 2026

  • Investors
  • Employee Count
    28

Products & Services of Neuome

Neuome offers a comprehensive portfolio of products and services, including instaPRESERVE, InstaDetect, and Biobank.

instaPRESERVE
Biospecimen Technology

Preserves biospecimens without cold-chain for stability.

InstaDetect
Pathogen Detection

Provides ultrasensitive point-of-care pathogen testing.

Biobank
Biobanking Service

Offers reliable solutions for biosample storage and management.

Funding Insights of Neuome

Neuome has successfully raised a total of $361.96K through 1 strategic funding round. The most recent funding activity was a Seed round of $361.96 thousand completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $361,956
  • Total Rounds 1
  • Last Round Seed β€” $361,956
  • First Round $361,956

    (Jul 2026)

  • Investors Count 1

All 1 funding rounds of Neuome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2026$361,956Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in Neuome

Neuome has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dr Lal PathLabs.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
lalpathlabs.com
Premium access

Investor details for Neuome

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Neuome Technologies Private Limited (Neuome)

Neuome Technologies Private Limited is the primary company behind Neuome. The board of Neuome Technologies Private Limited currently have 3 directors; the longest-serving is Rajani Kanth Vangala, appointed in 2020. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajani Kanth Vangala
DIN 01806806
Managing Director20 May 20206 yrs 5 moNeuome Technologies Private Limited
Subrahmanyam Pochinnapeddi
DIN 08172605
Director01 Apr 20215 yrs 6 moNeuome Technologies Private Limited
Guntupalli Siva Rama Krishna Prasad
DIN 00009408
Director27 May 20242 yrs 5 moNeuome Technologies Private Limited

People of Neuome

2 people are tracked at Neuome (2 in leadership); the tracked headcount is 28.

NameRoleGroup
Co-Founder & CEOLeadership
Dr. Rajani Kanth Vangala
Co-Founder and CEOLeadership
Premium access

Complete people profiles for Neuome

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Neuome

Figures of Neuome Technologies Private Limited, the primary company behind Neuome, for FY 2025. Revenue was ₹14.3 Lakh (-97% year on year). Net loss was -₹1.07 Cr (-747% margin). EBITDA was -₹68.8 Lakh (-480% margin). Revenue has grown at a compounded annual rate of -68% over three years.

  • ₹14.3 LakhRevenue · FY 2025 · -97% YoY
  • -₹1.07 CrNet loss · -747% margin
  • -₹68.8 LakhEBITDA · -480% margin
  • ₹2.6 LakhPaid-up capital
  • 28Employees (provident fund records)
  • -68%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Neuome Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Neuome

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Neuome

2 dated milestones of Neuome across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Neuome is founded.
  2. Funding First funding round of $362K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Neuome

Neuome was founded in 2020 and raised its 1st funding round 6 years after it was founded.

Neuome is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Rajani Kanth Vangala is the CEO of Neuome, as recorded in our data. They have also founded this company.

Neuome is a funded company, having raised a total of $361.96K across 1 funding round to date. The company's 1st funding round was a Seed of $361.96K, raised on Jul 2026.

Neuome has 28 employees.

The primary company behind Neuome, Neuome Technologies Private Limited, reported revenue of β‚Ή14.3 Lakh for FY 2025, down 97% year on year.

Neuome was founded in 2020 and is based in Bengaluru, India. Technologies for therapeutic, prophylactic, and diagnostic applications in the lifesciences sector are developed by the company. Key products include the InstaDetect Pathogen Diagnostic Kit Platform and the InstaPreserve RT system for biospecimen collection, transport, and storage. Research services are provided to tackle challenges in pharmaceutical and biotechnology research and development.

Neuome offers instaPRESERVE, InstaDetect, and Biobank.

Neuome has 1 investor. Key investors include Dr Lal PathLabs.

Neuome operates through Neuome Technologies Private Limited.

The legal entities of Neuome currently have 3 directors, including Rajani Kanth Vangala, Subrahmanyam Pochinnapeddi, Guntupalli Siva Rama Krishna Prasad.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available